pyrazines has been researched along with Carotid Artery Thrombosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, GB; Jain, MK; Lin, Z; Nayak, L; Schmaier, AH; Shi, H | 1 |
| Kawamura, M; Moriya, N; Terashita, Z; Tsuji, N | 1 |
2 other study(ies) available for pyrazines and Carotid Artery Thrombosis
| Article | Year |
|---|---|
The thromboprotective effect of bortezomib is dependent on the transcription factor Kruppel-like factor 2 (KLF2).
Topics: Animals; Boronic Acids; Bortezomib; Carotid Artery Thrombosis; Cells, Cultured; Coronary Occlusion; Cytoprotection; Human Umbilical Vein Endothelial Cells; Humans; Kruppel-Like Transcription Factors; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrazines; Whole Blood Coagulation Time | 2014 |
Effects of TAK-029, a novel GPIIb/IIIa antagonist, on arterial thrombosis in guinea pigs, dogs and monkeys.
Topics: Animals; Basilar Artery; Bleeding Time; Carotid Artery Thrombosis; Coronary Thrombosis; Disease Models, Animal; Dogs; Female; Guanidines; Guinea Pigs; Injections, Intravenous; Macaca fascicularis; Male; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Pyrazines; Thrombosis | 1997 |